Valuation : Illumina, Inc.

Market Cap 32.95B 28.34B 26.65B 24.33B 45.5B 3,116B 45.65B 316B 122B 1,596B 124B 121B 5,083B P/E 2026 *
44.1x
P/E 2027 * 37.3x
Enterprise Value 33.2B 28.55B 26.85B 24.51B 45.84B 3,140B 45.99B 318B 123B 1,608B 125B 122B 5,121B EV / Sales 2026 *
7.18x
EV / Sales 2027 * 6.56x
Free-Float
74.98%
Yield 2026 *
-
Yield 2027 * -
1 day-1.55%
1 week+1.22%
Current month+2.15%
1 month+12.65%
3 months+34.44%
6 months+75.11%
Current year+66.38%
1 week 206.82
Extreme 206.82
221.76
1 month 186.64
Extreme 186.64
231.81
Current year 112.65
Extreme 112.65
231.81
1 year 88
Extreme 88
231.81
3 years 68.7
Extreme 68.7
231.81
5 years 68.7
Extreme 68.7
469.87
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 2023-09-24
Director of Finance/CFO 50 2024-04-14
Chief Tech/Sci/R&D Officer 55 2025-05-28
Director TitleAgeSince
Director/Board Member 65 2016-07-27
Director/Board Member 66 2016-12-31
Director/Board Member 65 2019-02-04
Date Insider Type Main position Quantity % Market Cap. Importance
8/27/26
Corvex Management LP
SellCompany -138,379 0.0915%
8/25/26 Other

Director

0 0%
8/21/26
Corvex Management LP
SellCompany -299,336 0.1978%
Change 5-day change 1-year change 3-year change Capi.($)
-1.55%+1.22%+120.58%+36.40% 32.95B
-0.75%-1.35%+24.60%+14.36% 227B
-1.60%-3.89%+3.72%-19.20% 146B
-0.85%-1.58%-21.45%+19.12% 130B
+1.81%+2.05%-55.42%-11.25% 69.27B
+0.13%-0.34%+11.07%+16.81% 51.82B
-0.97%-1.30%-18.76%-15.08% 50.45B
+0.59%-1.94%+17.17%+27.91% 42.53B
-1.01%-1.28%+33.64%+50.03% 40.22B
-0.37%-4.98%-17.58%+48.93% 32.94B
Average -0.45%-1.34%+9.76%+16.80% 82.27B
Weighted average by Cap. -0.62%-1.55%+5.61%+10.06%

Financials

2026 *2027 *
Net sales 4.62B 3.98B 3.74B 3.41B 6.39B 437B 6.41B 44.35B 17.14B 224B 17.37B 16.99B 713B 4.91B 4.22B 3.97B 3.63B 6.78B 464B 6.8B 47.1B 18.21B 238B 18.44B 18.04B 758B
Net income 760M 654M 615M 561M 1.05B 71.91B 1.05B 7.29B 2.82B 36.82B 2.86B 2.79B 117B 891M 766M 721M 658M 1.23B 84.29B 1.23B 8.55B 3.3B 43.16B 3.35B 3.27B 137B
Net Debt 246M 212M 199M 182M 340M 23.27B 341M 2.36B 912M 11.92B 924M 904M 37.95B -729M -627M -590M -538M -1.01B -68.94B -1.01B -6.99B -2.7B -35.31B -2.74B -2.68B -112B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
26-09-04 US$218.22 -1.55% 1,748,198
26-09-03 US$221.66 +3.94% 1,716,855
26-09-02 US$213.25 +2.95% 1,771,946
26-09-01 US$207.13 -3.04% 1,501,398
26-08-31 US$213.63 -0.91% 2,017,763
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
218.22USD
Average target price
199.63USD
Spread / Average Target
-8.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!